Epidemic Clostridium difficile Strains Demonstrate Increased Competitive Fitness Compared to Nonepidemic Isolates

ABSTRACT Clostridium difficile infection is the most common cause of severe cases of antibiotic-associated diarrhea (AAD) and is a significant health burden. Recent increases in the rate of C. difficile infection have paralleled the emergence of a specific phylogenetic clade of C. difficile strains (ribotype 027; North American pulsed-field electrophoresis 1 [NAP1]; restriction endonuclease analysis [REA] group BI). Initial reports indicated that ribotype 027 strains were associated with increased morbidity and mortality and might be hypervirulent. Although subsequent work has raised some doubt as to whether ribotype 027 strains are hypervirulent, the strains are considered epidemic isolates that have caused severe outbreaks across the globe. We hypothesized that one factor that could lead to the increased prevalence of ribotype 027 strains would be if these strains had increased competitive fitness compared to strains of other ribotypes. We developed a moderate-throughput in vitro model of C. difficile infection and used it to test competition between four ribotype 027 clinical isolates and clinical isolates of four other ribotypes (001, 002, 014, and 053). We found that ribotype 027 strains outcompeted the strains of other ribotypes. A similar competitive advantage was observed when two ribotype pairs were competed in a mouse model of C. difficile infection. Based upon these results, we conclude that one possible mechanism through which ribotype 027 strains have caused outbreaks worldwide is their increased ability to compete in the presence of a complex microbiota.

[1]  Martin Wu,et al.  Surprisingly extensive mixed phylogenetic and ecological signals among bacterial Operational Taxonomic Units , 2013, Nucleic acids research.

[2]  K. R. Clarke,et al.  Non‐parametric multivariate analyses of changes in community structure , 1993 .

[3]  W. Moore,et al.  Taxonomic Note : A Place for DNA-DNA Reassociation and 16 s rRNA Sequence Analysis in the Present Species Definition in , 2022 .

[4]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[5]  H. V. van Leeuwen,et al.  Genetic markers for Clostridium difficile lineages linked to hypervirulence. , 2011, Microbiology.

[6]  D. Pardi,et al.  Clostridium difficile-associated diarrhea and colitis. , 2001, Mayo Clinic proceedings.

[7]  J. V. van Dissel,et al.  Spectrum of Clostridium difficile infections outside health care facilities , 2008, Canadian Medical Association Journal.

[8]  J. Bartlett.  Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease , 2006, Annals of Internal Medicine.

[9]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[10]  O. Dekkers,et al.  All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  N. Minton,et al.  Spores of Clostridium difficile Clinical Isolates Display a Diverse Germination Response to Bile Salts , 2012, PloS one.

[12]  Erko Stackebrandt,et al.  Taxonomic Note: A Place for DNA-DNA Reassociation and 16S rRNA Sequence Analysis in the Present Species Definition in Bacteriology , 1994 .

[13]  Joseph A. Sorg,et al.  Muricholic Acids Inhibit Clostridium difficile Spore Germination and Growth , 2013, PloS one.

[14]  Stuart Johnson,et al.  An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.

[15]  W. D. de Vos,et al.  Evaluating the microbial diversity of an in vitro model of the human large intestine by phylogenetic microarray analysis. , 2010, Microbiology.

[16]  G. Gibson,et al.  Impact of GanedenBC30 (Bacillus coagulans GBI-30, 6086) on population dynamics of the human gut microbiota in a continuous culture fermentation system , 2011 .

[17]  Sarah A. Ewing,et al.  Clostridium difficile Ribotype Diversity at Six Health Care Institutions in the United States , 2013, Journal of Clinical Microbiology.

[18]  Sarah A. Ewing,et al.  Detection of Mixed Populations of Clostridium difficile from Symptomatic Patients Using Capillary-Based Polymerase Chain Reaction Ribotyping , 2013, Infection Control & Hospital Epidemiology.

[19]  Joseph A. Sorg,et al.  Laboratory Maintenance of Clostridium difficile , 2009, Current protocols in microbiology.

[20]  Hilary G. Morrison,et al.  Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation , 2009, Infection and Immunity.

[21]  P. Schloss.  A High-Throughput DNA Sequence Aligner for Microbial Ecology Studies , 2009, PloS one.

[22]  Cecilia Jernberg,et al.  Long-term impacts of antibiotic exposure on the human intestinal microbiota. , 2010, Microbiology.

[23]  M. Dionne,et al.  A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  L. Valiquette,et al.  Lack of Association between Clinical Outcome of Clostridium difficile Infections, Strain Type, and Virulence-Associated Phenotypes , 2011, Journal of Clinical Microbiology.

[25]  P. Legendre,et al.  vegan : Community Ecology Package. R package version 1.8-5 , 2007 .

[26]  R. Britton,et al.  Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. , 2012, Trends in microbiology.

[27]  M. Hu,et al.  Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[28]  Patrick D. Schloss,et al.  Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies , 2011, PloS one.

[29]  M. Unemo,et al.  Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1 , 2008, Journal of Clinical Microbiology.

[30]  N. Verlander,et al.  Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study , 2008, PloS one.

[31]  Mark A. Miller,et al.  Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  L. Valiquette,et al.  Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec , 2005, Canadian Medical Association Journal.

[33]  Jeffrey D Goldsmith,et al.  A mouse model of Clostridium difficile-associated disease. , 2008, Gastroenterology.

[34]  David Griffiths,et al.  Detection of Mixed Infection from Bacterial Whole Genome Sequence Data Allows Assessment of Its Role in Clostridium difficile Transmission , 2013, PLoS Comput. Biol..

[35]  D. Aronoff,et al.  The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. , 2013, Anaerobe.

[36]  Patrick D. Schloss,et al.  Assessing and Improving Methods Used in Operational Taxonomic Unit-Based Approaches for 16S rRNA Gene Sequence Analysis , 2011, Applied and Environmental Microbiology.

[37]  Rob Knight,et al.  UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..

[38]  M. Wilcox,et al.  Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut. , 2003, The Journal of antimicrobial chemotherapy.

[39]  K. Wilson,et al.  Interaction of Clostridium difficile and Escherichia coli with microfloras in continuous-flow cultures and gnotobiotic mice , 1986, Infection and immunity.

[40]  T. Peto,et al.  Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  G. Macfarlane,et al.  Validation of a Three-Stage Compound Continuous Culture System for Investigating the Effect of Retention Time on the Ecology and Metabolism of Bacteria in the Human Colon , 1998, Microbial Ecology.

[42]  Christy A. Varughese,et al.  Antibiotic-Associated Diarrhea , 2013, Journal of pharmacy practice.

[43]  Bartlett Jg.  Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis. , 1981 .

[44]  J. Bartlett.  Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis. , 1981, The Johns Hopkins medical journal.

[45]  E. Zoetendal,et al.  Microbial Community Development in a Dynamic Gut Model Is Reproducible, Colon Region Specific, and Selective for Bacteroidetes and Clostridium Cluster IX , 2010, Applied and Environmental Microbiology.

[46]  Mihai Pop,et al.  Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples , 2009, PLoS Comput. Biol..

[47]  M. Pirmohamed,et al.  Emergence and global spread of epidemic healthcare-associated Clostridium difficile , 2012, Nature Genetics.

[48]  V. Mai,et al.  Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea , 2013, Journal of Clinical Microbiology.

[49]  C. Nord,et al.  Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. , 2001, The Journal of antimicrobial chemotherapy.

[50]  C. Chassard,et al.  Advances and perspectives in in vitro human gut fermentation modeling. , 2012, Trends in biotechnology.

[51]  Patrick D Schloss,et al.  The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection , 2011, Gut microbes.

[52]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[53]  Sarah A. Ewing,et al.  Clostridium difficile ribotype does not predict severe infection. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  D. Gerding,et al.  Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production , 2010, Journal of bacteriology.

[55]  M. Wilcox,et al.  Mixed infection by Clostridium difficile in an in vitro model of the human gut. , 2013, The Journal of antimicrobial chemotherapy.

[56]  N. Minton,et al.  Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027 , 2011, PloS one.

[57]  D. Anderson,et al.  Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals , 2011, Infection Control & Hospital Epidemiology.

[58]  H. Myllykallio,et al.  Flavin-dependent thymidylate synthase X limits chromosomal DNA replication , 2008, Proceedings of the National Academy of Sciences.